PacBio provides longer read length than Illumina's short-length reads. Longer reads offer better opportunity for genome assembly, structural variant calling. It is not worse than short reads for calling SNP/indels, quantifying transcripts. Sounds like PacBio can do whatever Illumina platform can offer.
Would that be any reason for going with Illumina if PacBio's long reads can do everything and more?